XMT-1536

· Mersana Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XMT-1536, covering 2023-11-13 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b [Phase 1]